| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.819 | 0.003 | 0.819 | DNA directed RNA polymerase inhibitor | 0.656 0.003 DBMET02868 0.656 0.003 DBMET02869 0.598 0.004 DBMET02870 0.247 0.009 DBMET02871 | ||
| 0.783 | 0.001 | 0.783 | Transcription factor NF kappa B stimulant | 0.696 0.001 DBMET02868 0.696 0.001 DBMET02869 0.736 0.001 DBMET02870 | ||
| 0.762 | 0.025 | 0.762 | DNA directed DNA polymerase inhibitor | 0.471 0.091 DBMET02868 0.471 0.091 DBMET02869 0.363 0.132 DBMET02870 | ||
| 0.74 | 0.004 | 0.925 | DNA synthesis inhibitor | 0.766 0.004 DBMET02868 0.766 0.004 DBMET02869 0.925 0.002 DBMET02870 0.552 0.01 DBMET02871 | DBMET02870 | |
| 0.656 | 0.003 | 0.667 | RNA-directed DNA polymerase inhibitor | 0.646 0.004 DBMET02868 0.646 0.004 DBMET02869 0.667 0.003 DBMET02870 0.478 0.012 DBMET02871 | DBMET02870 | |
| 0.581 | 0.003 | 0.581 | HIV-1 reverse transcriptase inhibitor | 0.444 0.004 DBMET02868 0.444 0.004 DBMET02869 0.34 0.005 DBMET02870 0.136 0.017 DBMET02871 | ||
| 0.338 | 0.014 | 0.444 | Peptidyltransferase inhibitor | 0.429 0.005 DBMET02868 0.429 0.005 DBMET02869 0.444 0.005 DBMET02870 0.298 0.025 DBMET02871 | DBMET02870 | |
| 0.299 | 0.03 | 0.388 | Hepatoprotectant | 0.203 0.063 DBMET02868 0.203 0.063 DBMET02869 0.388 0.014 DBMET02870 | DBMET02870 | |
| 0.189 | 0.046 | 0.211 | Lipid peroxidase inhibitor | 0.211 0.037 DBMET02870 | DBMET02870 | |
| 0.149 | 0.05 | 0.244 | DNA polymerase I inhibitor | 0.227 0.021 DBMET02868 0.227 0.021 DBMET02869 0.244 0.018 DBMET02870 0.114 0.073 DBMET02871 | DBMET02870 | |
| 0.118 | 0.035 | 0.118 | Acetylcholine M3 receptor agonist | 0.073 0.068 DBMET02870 | ||
| 0.086 | 0.018 | 0.279 | Antimetabolite | 0.206 0.009 DBMET02868 0.206 0.009 DBMET02869 0.196 0.01 DBMET02870 0.279 0.006 DBMET02871 | DBMET02871 | |
| 0.031 | 0.011 | 0.085 | Thymidine phosphorylase inhibitor | 0.027 0.016 DBMET02868 0.027 0.016 DBMET02869 0.085 0.003 DBMET02871 | DBMET02871 | |
| 0.057 | 0.038 | 0.149 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.121 0.011 DBMET02868 0.121 0.011 DBMET02869 0.149 0.009 DBMET02870 0.144 0.009 DBMET02871 | DBMET02870 | |
| 0.023 | 0.025 | 0.043 | Uridine phosphorylase inhibitor | 0.043 0.01 DBMET02871 | DBMET02871 | |
| 0.008 | 0.013 | 0.011 | Purinergic P2Y2 agonist | 0.011 0.006 DBMET02870 0.01 0.008 DBMET02871 | DBMET02870 | |
| 0.01 | 0.016 | 0.015 | Purinergic P2 agonist | 0.015 0.011 DBMET02870 | DBMET02870 | |
| 0.01 | 0.016 | 0.015 | Purinergic receptor agonist | 0.015 0.011 DBMET02870 | DBMET02870 | |
| 0.008 | 0.016 | 0.011 | Purinergic P2Y agonist | 0.011 0.01 DBMET02870 | DBMET02870 | |
| 0.048 | 0.058 | 0.143 | Carbamoyl phosphate synthetase inhibitor | 0.128 0.014 DBMET02868 0.128 0.014 DBMET02869 0.075 0.032 DBMET02870 0.143 0.012 DBMET02871 | DBMET02871 | |
| 0.084 | 0.104 | 0.137 | Mucolytic | 0.137 0.04 DBMET02868 0.137 0.04 DBMET02869 0.097 0.082 DBMET02870 | DBMET02869 | |
| 0.037 | 0.058 | 0.09 | Protein 50S ribosomal subunit inhibitor | 0.09 0.016 DBMET02870 | DBMET02870 | |
| 0.032 | 0.057 | 0.118 | Thymidylate synthase inhibitor | 0.05 0.028 DBMET02868 0.05 0.028 DBMET02869 0.118 0.004 DBMET02871 | DBMET02871 | |
| 0.107 | 0.141 | 0.272 | Aurora-C kinase inhibitor | 0.272 0.007 DBMET02871 | DBMET02871 | |
| 0.025 | 0.067 | 0.062 | Antibiotic Aminoglycoside-like | 0.062 0.008 DBMET02870 | DBMET02870 | |
| 0.163 | 0.213 | 0.521 | Immunomodulator | 0.246 0.118 DBMET02870 0.521 0.02 DBMET02871 | DBMET02871 | |
| 0.008 | 0.062 | 0.268 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.268 0.002 DBMET02870 | DBMET02870 | |
| 0.037 | 0.094 | 0.155 | Phosphofructokinase-1 inhibitor | 0.107 0.029 DBMET02868 0.107 0.029 DBMET02869 0.155 0.017 DBMET02870 0.118 0.026 DBMET02871 | DBMET02870 | |
| 0.065 | 0.123 | 0.144 | UDP-glucose 4-epimerase inhibitor | 0.086 0.08 DBMET02868 0.086 0.08 DBMET02869 0.144 0.031 DBMET02870 0.135 0.035 DBMET02871 | DBMET02870 | |
| 0.027 | 0.087 | 0.052 | Thymidine kinase inhibitor | 0.041 0.029 DBMET02868 0.041 0.029 DBMET02869 0.052 0.018 DBMET02871 | DBMET02871 | |
| 0.18 | 0.255 | 0.564 | Antibacterial | 0.26 0.168 DBMET02868 0.26 0.168 DBMET02869 0.564 0.025 DBMET02870 0.299 0.136 DBMET02871 | DBMET02870 | |
| 0.021 | 0.098 | 0.071 | Ornithine carbamoyltransferase inhibitor | 0.049 0.04 DBMET02868 0.049 0.04 DBMET02869 0.071 0.025 DBMET02871 | DBMET02871 | |
| 0.059 | 0.138 | 0.13 | Uric acid excretion stimulant | 0.13 0.032 DBMET02871 | DBMET02871 | |
| 0.081 | 0.161 | 0.211 | Interleukin 4 antagonist | 0.107 0.106 DBMET02870 0.211 0.02 DBMET02871 | DBMET02871 | |
| 0.006 | 0.094 | 0.041 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.026 0.021 DBMET02868 0.026 0.021 DBMET02869 0.041 0.012 DBMET02871 | DBMET02871 | |
| 0.055 | 0.149 | 0.107 | Expectorant | 0.104 0.065 DBMET02868 0.104 0.065 DBMET02869 0.107 0.061 DBMET02870 | DBMET02870 | |
| 0.039 | 0.138 | 0.056 | Adenine nucleotide translocase inhibitor | 0.056 0.036 DBMET02870 | DBMET02870 | |
| 0.024 | 0.129 | 0.123 | Argininosuccinate synthase inhibitor | 0.052 0.044 DBMET02868 0.052 0.044 DBMET02869 0.123 0.015 DBMET02871 | DBMET02871 | |
| 0.039 | 0.17 | 0.105 | Glutamate dehydrogenase inhibitor | 0.077 0.048 DBMET02868 0.077 0.048 DBMET02869 0.105 0.028 DBMET02871 | DBMET02871 | |
| 0.063 | 0.2 | 0.144 | Adenylate kinase inhibitor | 0.144 0.029 DBMET02871 | DBMET02871 | |
| 0.01 | 0.149 | 0.04 | Fumarate hydratase inhibitor | 0.04 0.018 DBMET02871 | DBMET02871 | |
| 0.051 | 0.191 | 0.173 | NADH dehydrogenase inhibitor | 0.086 0.064 DBMET02868 0.086 0.064 DBMET02869 0.159 0.016 DBMET02870 0.173 0.013 DBMET02871 | DBMET02871 | |
| 0.089 | 0.245 | 0.277 | Immunostimulant | 0.277 0.086 DBMET02870 | DBMET02870 | |
| 0.14 | 0.298 | 0.535 | Toll-Like receptor 7 agonist | 0.535 0.026 DBMET02871 | DBMET02871 | |
| 0.016 | 0.186 | 0.055 | Acyl-CoA dehydrogenase inhibitor | 0.055 0.037 DBMET02871 | DBMET02871 | |
| 0.134 | 0.307 | 0.537 | Toll-Like receptor agonist | 0.537 0.025 DBMET02871 | DBMET02871 | |
| 0.042 | 0.247 | 0.093 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.093 0.062 DBMET02871 | DBMET02871 | |
| 0.083 | 0.294 | 0.309 | Antioxidant | 0.309 0.058 DBMET02870 | DBMET02870 | |
| 0.005 | 0.223 | 0.019 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.019 0.015 DBMET02870 | DBMET02870 | |
| 0.038 | 0.266 | 0.121 | Alkylator | 0.121 0.067 DBMET02871 | DBMET02871 | |
| 0.008 | 0.252 | 0.028 | Protein 30S ribosomal subunit inhibitor | 0.028 0.014 DBMET02870 | DBMET02870 | |
| 0.017 | 0.277 | 0.045 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.045 0.021 DBMET02871 | DBMET02871 | |
| 0.042 | 0.306 | 0.135 | Interleukin 5 antagonist | 0.135 0.016 DBMET02871 | DBMET02871 | |
| 0.011 | 0.276 | 0.061 | Xanthine dehydrogenase inhibitor | 0.061 0.037 DBMET02871 | DBMET02871 | |
| 0.121 | 0.39 | 0.419 | Interleukin 2 agonist | 0.419 0.022 DBMET02870 | DBMET02870 | |
| 0.037 | 0.326 | 0.114 | Alpha-N-acetylglucosaminidase inhibitor | 0.114 0.084 DBMET02871 | DBMET02871 | |
| 0.012 | 0.311 | 0.135 | Biliverdin reductase inhibitor | 0.135 0.011 DBMET02871 | DBMET02871 | |
| 0.056 | 0.359 | 0.261 | DNA methylase inhibitor | 0.134 0.133 DBMET02868 0.134 0.133 DBMET02869 0.261 0.042 DBMET02871 | DBMET02871 | |
| 0.033 | 0.348 | 0.084 | Xanthine oxidase inhibitor | 0.084 0.082 DBMET02871 | DBMET02871 | |
| 0.099 | 0.447 | 0.278 | Nitric-oxide synthase stimulant | 0.278 0.018 DBMET02871 | DBMET02871 | |
| 0.006 | 0.375 | 0.038 | Guanylate cyclase 1 stimulant | 0.038 0.005 DBMET02871 | DBMET02871 | |
| 0.054 | 0.425 | 0.206 | DNA damaging | 0.206 0.111 DBMET02871 | DBMET02871 | |
| 0.011 | 0.384 | 0.09 | Neuraminidase (Influenza A) inhibitor | 0.09 0.004 DBMET02870 | DBMET02870 | |
| 0.035 | 0.411 | 0.147 | Cell wall synthesis inhibitor | 0.147 0.068 DBMET02870 0.143 0.072 DBMET02871 | DBMET02870 | |
| 0.006 | 0.383 | 0.029 | Purinergic P2Y15 antagonist | 0.029 0.018 DBMET02871 | DBMET02871 | |
| 0.019 | 0.411 | 0.084 | Interferon inducer | 0.084 0.021 DBMET02871 | DBMET02871 | |
| 0.014 | 0.407 | 0.049 | Dopamine beta hydroxylase inhibitor | 0.049 0.033 DBMET02871 | DBMET02871 | |
| 0.005 | 0.411 | 0.102 | Antineoplastic antibiotic | 0.102 0.045 DBMET02870 | DBMET02870 | |
| 0.048 | 0.46 | 0.134 | DNA repair enzyme inhibitor | 0.11 0.095 DBMET02870 0.134 0.05 DBMET02871 | DBMET02871 | |
| 0.011 | 0.432 | 0.048 | AICAR transformylase inhibitor | 0.048 0.024 DBMET02871 | DBMET02871 | |
| 0.016 | 0.444 | 0.096 | Interferon agonist | 0.096 0.032 DBMET02871 | DBMET02871 | |
| 0.042 | 0.476 | 0.109 | Glutamate release inhibitor | 0.109 0.031 DBMET02871 | DBMET02871 | |
| 0.034 | 0.479 | 0.239 | DNA methyltransferase I inhibitor | 0.239 0.052 DBMET02871 | DBMET02871 | |
| 0.023 | 0.476 | 0.063 | Glutamate (mGluR6) antagonist | 0.063 0.056 DBMET02871 | DBMET02871 | |
| 0.028 | 0.485 | 0.094 | Adenylate cyclase inhibitor | 0.094 0.09 DBMET02871 | DBMET02871 | |
| 0.01 | 0.47 | 0.047 | Aconitate hydratase inhibitor | 0.047 0.044 DBMET02871 | DBMET02871 | |
| 0.012 | 0.473 | 0.091 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.091 0.021 DBMET02871 | DBMET02871 | |
| 0.027 | 0.503 | 0.12 | DOPA decarboxylase inhibitor | 0.12 0.045 DBMET02871 | DBMET02871 | |
| 0.017 | 0.496 | 0.221 | GABA C receptor agonist | 0.221 0.017 DBMET02871 | DBMET02871 | |
| 0.076 | 0.56 | 0.129 | Ca2+-transporting ATPase inhibitor | 0.129 0.124 DBMET02871 | DBMET02871 | |
| 0.004 | 0.491 | 0.094 | Adenosine A2a receptor antagonist | 0.094 0.027 DBMET02871 | DBMET02871 | |
| 0.003 | 0.493 | 0.031 | Potassium channel small-conductance Ca-activated activator | 0.031 0.022 DBMET02871 | DBMET02871 | |
| 0.008 | 0.508 | 0.081 | Phenylalanine 4-hydroxylase inhibitor | 0.081 0.037 DBMET02871 | DBMET02871 | |
| 0.004 | 0.51 | 0.064 | Adenosine A1 receptor antagonist | 0.064 0.036 DBMET02871 | DBMET02871 | |
| 0.016 | 0.538 | 0.076 | Adenosine A3 receptor antagonist | 0.076 0.049 DBMET02871 | DBMET02871 | |
| 0.001 | 0.528 | 0.017 | Cyclin T1 inhibitor | 0.017 0.015 DBMET02871 | DBMET02871 | |
| 0.017 | 0.547 | 0.048 | Antiviral (Hepatitis D) | 0.048 0.04 DBMET02871 | DBMET02871 | |
| 0.062 | 0.596 | 0.236 | Calcium channel activator | 0.236 0.164 DBMET02871 | DBMET02871 | |
| 0.011 | 0.546 | 0.07 | Guanylate cyclase stimulant | 0.07 0.01 DBMET02871 | DBMET02871 | |
| 0.031 | 0.569 | 0.146 | Adenylate cyclase stimulant | 0.146 0.069 DBMET02871 | DBMET02871 | |
| 0.006 | 0.547 | 0.176 | Selectin antagonist | 0.176 0.014 DBMET02870 | DBMET02870 | |
| 0.101 | 0.656 | 0.451 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.451 0.061 DBMET02871 | DBMET02871 | |
| 0.011 | 0.567 | 0.084 | Phospholipase D inhibitor | 0.084 0.029 DBMET02871 | DBMET02871 | |
| 0.022 | 0.581 | 0.096 | Granulocyte macrophage colony stimulating factor agonist | 0.096 0.04 DBMET02871 | DBMET02871 | |
| 0.006 | 0.57 | 0.147 | Protein kinase C epsilon inhibitor | 0.147 0.006 DBMET02871 | DBMET02871 | |
| 0.003 | 0.574 | 0.116 | Adenosine A2 receptor antagonist | 0.116 0.023 DBMET02871 | DBMET02871 | |
| 0.002 | 0.587 | 0.024 | Glutamate (mGluR1a) agonist | 0.024 0.013 DBMET02871 | DBMET02871 | |
| 0.015 | 0.604 | 0.245 | MAP kinase 13 inhibitor | 0.245 0.011 DBMET02871 | DBMET02871 | |
| 0.024 | 0.621 | 0.152 | Peroxidase inhibitor | 0.152 0.077 DBMET02871 | DBMET02871 | |
| 0.029 | 0.639 | 0.112 | Transcription factor STAT6 inhibitor | 0.112 0.076 DBMET02871 | DBMET02871 | |
| 0.007 | 0.617 | 0.1 | Secretase beta inhibitor | 0.1 0.018 DBMET02871 | DBMET02871 | |
| 0.075 | 0.686 | 0.211 | 5 Hydroxytryptamine uptake stimulant | 0.211 0.131 DBMET02871 | DBMET02871 | |
| 0.011 | 0.623 | 0.202 | Protein kinase C nu inhibitor | 0.202 0.046 DBMET02871 | DBMET02871 | |
| 0.012 | 0.624 | 0.178 | Ferrochelatase inhibitor | 0.178 0.028 DBMET02871 | DBMET02871 | |
| 0.029 | 0.645 | 0.145 | Hexokinase inhibitor | 0.145 0.084 DBMET02871 | DBMET02871 | |
| 0.014 | 0.642 | 0.055 | Sodium/calcium exchanger inhibitor | 0.055 0.026 DBMET02871 | DBMET02871 | |
| 0.005 | 0.636 | 0.184 | Bruton tyrosine kinase inhibitor | 0.184 0.005 DBMET02871 | DBMET02871 | |
| 0.023 | 0.66 | 0.179 | Cyclic AMP phosphodiesterase inhibitor | 0.179 0.112 DBMET02871 | DBMET02871 | |
| 0.02 | 0.697 | 0.162 | GABA C receptor rho-2 antagonist | 0.162 0.058 DBMET02871 | DBMET02871 | |
| 0.005 | 0.685 | 0.068 | Protein kinase C theta inhibitor | 0.068 0.025 DBMET02871 | DBMET02871 | |
| 0.009 | 0.691 | 0.134 | GABA C receptor antagonist | 0.134 0.04 DBMET02871 | DBMET02871 | |
| 0.004 | 0.686 | 0.048 | Histamine H2 receptor agonist | 0.048 0.024 DBMET02871 | DBMET02871 | |
| 0.016 | 0.699 | 0.088 | mTOR complex 2 inhibitor | 0.088 0.05 DBMET02871 | DBMET02871 | |
| 0.071 | 0.758 | 0.188 | 5 Hydroxytryptamine 3E antagonist | 0.188 0.087 DBMET02871 | DBMET02871 | |
| 0.002 | 0.69 | 0.017 | 5 Lipoxygenase activating protein inhibitor | 0.017 0.006 DBMET02871 | DBMET02871 | |
| 0.004 | 0.707 | 0.032 | Protein kinase (CK2) beta inhibitor | 0.032 0.027 DBMET02871 | DBMET02871 | |
| 0.01 | 0.715 | 0.118 | GABA C receptor rho-1 antagonist | 0.118 0.042 DBMET02871 | DBMET02871 | |
| 0.036 | 0.741 | 0.436 | GABA C receptor rho-3 antagonist | 0.436 0.047 DBMET02871 | DBMET02871 | |
| 0.009 | 0.715 | 0.16 | 5 Hydroxytryptamine 3A agonist | 0.16 0.03 DBMET02871 | DBMET02871 | |
| 0.068 | 0.777 | 0.192 | MAP kinase kinase 3 inhibitor | 0.192 0.148 DBMET02871 | DBMET02871 | |
| 0.006 | 0.718 | 0.104 | MAP kinase kinase 1 inhibitor | 0.104 0.052 DBMET02871 | DBMET02871 | |
| 0.01 | 0.724 | 0.052 | Dihydroorotate oxidase inhibitor | 0.052 0.044 DBMET02871 | DBMET02871 | |
| 0.013 | 0.729 | 0.307 | Angiogenesis stimulant | 0.307 0.047 DBMET02870 | DBMET02870 | |
| 0.027 | 0.745 | 0.131 | MAP kinase 3 inhibitor | 0.131 0.104 DBMET02871 | DBMET02871 | |
| 0.008 | 0.73 | 0.278 | MAP kinase kinase 2 inhibitor | 0.278 0.043 DBMET02871 | DBMET02871 | |
| 0.003 | 0.727 | 0.045 | Histamine H1 receptor agonist | 0.045 0.027 DBMET02871 | DBMET02871 | |
| 0.004 | 0.729 | 0.092 | Cyclin-dependent kinase 9 inhibitor | 0.092 0.073 DBMET02871 | DBMET02871 | |
| 0.012 | 0.753 | 0.103 | Electrolyte absorption antagonist | 0.103 0.053 DBMET02871 | DBMET02871 | |
| 0.005 | 0.754 | 0.101 | Neuraminidase (influenza) inhibitor | 0.101 0.016 DBMET02870 | DBMET02870 | |
| 0.009 | 0.762 | 0.183 | MAP kinase 12 inhibitor | 0.183 0.028 DBMET02871 | DBMET02871 | |
| 0.007 | 0.76 | 0.087 | Myeloperoxidase inhibitor | 0.087 0.053 DBMET02871 | DBMET02871 | |
| 0.003 | 0.758 | 0.048 | Adenosine A2b receptor antagonist | 0.048 0.036 DBMET02871 | DBMET02871 | |
| 0.04 | 0.798 | 0.203 | 5 Hydroxytryptamine release stimulant | 0.203 0.119 DBMET02871 | DBMET02871 | |
| 0.003 | 0.763 | 0.094 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.094 0.052 DBMET02871 | DBMET02871 | |
| 0.009 | 0.777 | 0.155 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.155 0.085 DBMET02871 | DBMET02871 | |
| 0.004 | 0.783 | 0.172 | Glycogen synthase kinase-3 alpha inhibitor | 0.172 0.052 DBMET02871 | DBMET02871 | |
| 0.004 | 0.786 | 0.177 | TRKA antagonist | 0.177 0.037 DBMET02871 | DBMET02871 | |
| 0.016 | 0.8 | 0.345 | Immunosuppressant | 0.209 0.188 DBMET02870 0.345 0.09 DBMET02871 | DBMET02871 | |
| 0.005 | 0.796 | 0.08 | Janus tyrosine kinase 2 inhibitor | 0.08 0.047 DBMET02871 | DBMET02871 | |
| 0.004 | 0.799 | 0.069 | ErbB-4 antagonist | 0.069 0.061 DBMET02871 | DBMET02871 | |
| 0.004 | 0.8 | 0.163 | Janus tyrosine kinase 3 inhibitor | 0.163 0.016 DBMET02871 | DBMET02871 | |
| 0.002 | 0.806 | 0.059 | Pim-2 kinase inhibitor | 0.059 0.032 DBMET02871 | DBMET02871 | |
| 0.002 | 0.807 | 0.166 | Pim-3 kinase inhibitor | 0.166 0.014 DBMET02871 | DBMET02871 | |
| 0.026 | 0.832 | 0.176 | NOS3 expression enhancer | 0.176 0.052 DBMET02870 | DBMET02870 | |
| 0.002 | 0.813 | 0.126 | Protein kinase (CK2) inhibitor | 0.126 0.044 DBMET02871 | DBMET02871 | |
| 0.004 | 0.817 | 0.034 | Tryptophan 5 hydroxylase inhibitor | 0.034 0.032 DBMET02871 | DBMET02871 | |
| 0.004 | 0.818 | 0.098 | Neuraminidase inhibitor | 0.098 0.016 DBMET02870 | DBMET02870 | |
| 0.004 | 0.82 | 0.137 | Aurora-A kinase inhibitor | 0.137 0.046 DBMET02871 | DBMET02871 | |
| 0.006 | 0.822 | 0.021 | Granulocyte colony stimulating factor receptor agonist | 0.021 0.007 DBMET02871 | DBMET02871 | |
| 0.005 | 0.826 | 0.194 | I kappa B kinase epsilon inhibitor | 0.194 0.076 DBMET02871 | DBMET02871 | |
| 0.003 | 0.825 | 0.182 | Tyrosine-protein kinase receptor antagonist | 0.182 0.048 DBMET02871 | DBMET02871 | |
| 0.016 | 0.843 | 0.142 | CF transmembrane conductance regulator agonist | 0.142 0.091 DBMET02871 | DBMET02871 | |
| 0.002 | 0.838 | 0.072 | Fibroblast growth factor 3 antagonist | 0.072 0.062 DBMET02871 | DBMET02871 | |
| 0.003 | 0.843 | 0.233 | LIM domain kinase 1 inhibitor | 0.233 0.047 DBMET02871 | DBMET02871 | |
| 0.004 | 0.846 | 0.092 | Insulin receptor antagonist | 0.092 0.074 DBMET02871 | DBMET02871 | |
| 0.007 | 0.85 | 0.136 | Nitric oxide antagonist | 0.136 0.111 DBMET02870 | DBMET02870 | |
| 0.004 | 0.853 | 0.127 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.127 0.098 DBMET02871 | DBMET02871 | |
| 0.007 | 0.857 | 0.306 | Protein kinase (CK1) gamma 3 inhibitor | 0.306 0.016 DBMET02871 | DBMET02871 | |
| 0.005 | 0.855 | 0.146 | Cyclin-dependent kinase 8 inhibitor | 0.146 0.083 DBMET02871 | DBMET02871 | |
| 0.004 | 0.859 | 0.156 | Dyrk kinase inhibitor | 0.156 0.13 DBMET02871 | DBMET02871 | |
| 0.003 | 0.86 | 0.234 | Protein kinase (CK1) delta inhibitor | 0.234 0.02 DBMET02871 | DBMET02871 | |
| 0.002 | 0.86 | 0.094 | CDC7 inhibitor | 0.094 0.027 DBMET02871 | DBMET02871 | |
| 0.002 | 0.861 | 0.12 | Protein kinase (CK2) alpha inhibitor | 0.12 0.062 DBMET02871 | DBMET02871 | |
| 0.002 | 0.862 | 0.097 | Aurora-B kinase inhibitor | 0.097 0.085 DBMET02871 | DBMET02871 | |
| 0.006 | 0.866 | 0.219 | TRKC antagonist | 0.219 0.059 DBMET02871 | DBMET02871 | |
| 0.024 | 0.888 | 0.174 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.174 0.113 DBMET02871 | DBMET02871 | |
| 0.011 | 0.876 | 0.282 | Apoptosis agonist | 0.282 0.186 DBMET02870 | DBMET02870 | |
| 0.004 | 0.871 | 0.09 | MAP kinase 8 inhibitor | 0.09 0.073 DBMET02871 | DBMET02871 | |
| 0.005 | 0.874 | 0.304 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.304 0.03 DBMET02871 | DBMET02871 | |
| 0.016 | 0.888 | 0.1 | Toll-Like receptor 3 antagonist | 0.1 0.051 DBMET02871 | DBMET02871 | |
| 0.005 | 0.879 | 0.25 | Death-associated protein kinase 3 inhibitor | 0.25 0.052 DBMET02871 | DBMET02871 | |
| 0.004 | 0.881 | 0.275 | Protein kinase (CK1) gamma 2 inhibitor | 0.275 0.015 DBMET02871 | DBMET02871 | |
| 0.008 | 0.886 | 0.377 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.377 0.011 DBMET02871 | DBMET02871 | |
| 0.013 | 0.892 | 0.19 | Gastrin inhibitor | 0.19 0.163 DBMET02871 | DBMET02871 | |
| 0.002 | 0.884 | 0.046 | Dipeptidyl peptidase IV inhibitor | 0.046 0.027 DBMET02871 | DBMET02871 | |
| 0.005 | 0.887 | 0.094 | MAP kinase 11 inhibitor | 0.094 0.039 DBMET02871 | DBMET02871 | |
| 0.004 | 0.887 | 0.103 | TRKB antagonist | 0.103 0.096 DBMET02871 | DBMET02871 | |
| 0.005 | 0.889 | 0.314 | Protein kinase (CK1) gamma 1 inhibitor | 0.314 0.018 DBMET02871 | DBMET02871 | |
| 0.004 | 0.889 | 0.282 | Protein kinase (CK1) gamma inhibitor | 0.282 0.022 DBMET02871 | DBMET02871 | |
| 0.004 | 0.889 | 0.093 | MAP kinase 14 inhibitor | 0.093 0.039 DBMET02871 | DBMET02871 | |
| 0.006 | 0.895 | 0.213 | Protein-tyrosine kinase Lyn inhibitor | 0.213 0.041 DBMET02871 | DBMET02871 | |
| 0.004 | 0.896 | 0.085 | Hepatocyte growth factor antagonist | 0.085 0.068 DBMET02871 | DBMET02871 | |
| 0.005 | 0.897 | 0.13 | DNA intercalator | 0.13 0.052 DBMET02871 | DBMET02871 | |
| 0.002 | 0.896 | 0.07 | Rho-associated kinase I inhibitor | 0.07 0.057 DBMET02871 | DBMET02871 | |
| 0.004 | 0.898 | 0.141 | Vascular endothelial growth factor 3 antagonist | 0.141 0.074 DBMET02871 | DBMET02871 | |
| 0.005 | 0.9 | 0.225 | Polo-like kinase-3 inhibitor | 0.225 0.033 DBMET02871 | DBMET02871 | |
| 0.004 | 0.9 | 0.321 | CDC-like kinase 4 inhibitor | 0.321 0.027 DBMET02871 | DBMET02871 | |
| 0.003 | 0.9 | 0.305 | Clk dual-specificity kinase inhibitor | 0.305 0.038 DBMET02871 | DBMET02871 | |
| 0.004 | 0.902 | 0.334 | CDC-like kinase 2 inhibitor | 0.334 0.024 DBMET02871 | DBMET02871 | |
| 0.004 | 0.903 | 0.098 | Glycogen synthase kinase-3 beta inhibitor | 0.098 0.08 DBMET02871 | DBMET02871 | |
| 0.003 | 0.905 | 0.079 | Phosphatidylinositol 3-kinase delta inhibitor | 0.079 0.025 DBMET02871 | DBMET02871 | |
| 0.003 | 0.905 | 0.051 | Dipeptidyl peptidase inhibitor | 0.051 0.039 DBMET02871 | DBMET02871 | |
| 0.004 | 0.908 | 0.098 | Glycogen synthase kinase-3 inhibitor | 0.098 0.081 DBMET02871 | DBMET02871 | |
| 0.004 | 0.909 | 0.204 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.204 0.073 DBMET02871 | DBMET02871 | |
| 0.003 | 0.911 | 0.196 | Pim-1 kinase inhibitor | 0.196 0.015 DBMET02871 | DBMET02871 | |
| 0.003 | 0.913 | 0.208 | Protein kinase (CK1) inhibitor | 0.208 0.037 DBMET02871 | DBMET02871 | |
| 0.005 | 0.917 | 0.315 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.315 0.032 DBMET02871 | DBMET02871 | |
| 0.004 | 0.92 | 0.108 | Growth factor antagonist | 0.108 0.105 DBMET02871 | DBMET02871 | |
| 0.003 | 0.921 | 0.091 | Polo-like kinase-1 inhibitor | 0.091 0.06 DBMET02871 | DBMET02871 | |
| 0.003 | 0.922 | 0.155 | Rho-associated kinase inhibitor | 0.155 0.018 DBMET02871 | DBMET02871 | |
| 0.004 | 0.93 | 0.281 | Tyrosine kinase inhibitor | 0.281 0.047 DBMET02871 | DBMET02871 | |
| 0.003 | 0.934 | 0.111 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.111 0.045 DBMET02871 | DBMET02871 | |
| 0.003 | 0.94 | 0.071 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.071 0.066 DBMET02871 | DBMET02871 | |
| 0.002 | 0.941 | 0.064 | Raf kinase inhibitor | 0.064 0.061 DBMET02871 | DBMET02871 | |
| 0.004 | 0.946 | 0.201 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.201 0.076 DBMET02871 | DBMET02871 | |
| 0.003 | 0.946 | 0.102 | Vascular endothelial growth factor 2 antagonist | 0.102 0.07 DBMET02871 | DBMET02871 | |
| 0.008 | 0.951 | 0.069 | Phosphodiesterase VIII inhibitor | 0.069 0.056 DBMET02871 | DBMET02871 | |
| 0.009 | 0.955 | 0.104 | Toll-Like receptor 4 antagonist | 0.104 0.064 DBMET02870 | DBMET02870 | |
| 0.004 | 0.949 | 0.162 | Ribosomal protein S6 kinase inhibitor | 0.162 0.057 DBMET02871 | DBMET02871 | |
| 0.004 | 0.954 | 0.102 | p38 MAP kinase inhibitor | 0.102 0.032 DBMET02871 | DBMET02871 | |
| 0.004 | 0.955 | 0.11 | Vascular endothelial growth factor antagonist | 0.11 0.075 DBMET02871 | DBMET02871 | |
| 0.004 | 0.961 | 0.196 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.196 0.077 DBMET02871 | DBMET02871 | |
| 0.005 | 0.962 | 0.129 | Tumour necrosis factor antagonist | 0.129 0.128 DBMET02871 | DBMET02871 | |
| 0.003 | 0.963 | 0.064 | Phosphatidylinositol 3-kinase beta inhibitor | 0.064 0.022 DBMET02871 | DBMET02871 | |
| 0.004 | 0.992 | 0.333 | Antimitotic | 0.333 0.036 DBMET02871 | DBMET02871 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |